RARE CASE OF INFLAMMATORY CARCINOMA BREAST MISDIAGNOSED AS BREAST ABSCESS

Dr. Khan Mohd. Qasim, Dr. Janhavi Parulumar Kapadia

Abstract


Breast carcinoma which imitates an abscess is very rare and accounts for 1-5 % of all cases of breast carcinomas – this is frequently inflammatory carcinoma1. Such a manifestation of a neoplasm may provoke a late diagnosis and treatment

Keywords


Breast carcinoma, breast abscess, Inflammatory carcinoma breast

Full Text:

PDF

References


Stavros AT. Ultrasonografia piersi. Medipage; 2007676–681.

Sarkar S, Lahiri A, Bandyopadhyay S, Das S, Chakraborty T. Benign and malignant lesions of the breast: clinico-pathological perspective from a government teaching hospital in West Bengal, India. International Surgery Journal. 2018 Oct 26;5(11):3460-6.

Wingo PA, Jamison PM, Young JL, Gargiullo P. Population-based statistics for women diagnosed with inflammatory breast cancer (United States). Cancer Causes & Control. 2004 Apr 1;15(3):321-8.

"Facts for Life - Inflammatory Breast Cancer" (PDF). Susan G. Komen for the Cure. Retrieved 2006-12-02

"Inflammatory Breast Cancer Help—Signs and Symptoms." Inflammatory Breast Cancer Association. 02 Apr. 2009

Yamada T, Okazaki M, Okazaki A, Sato H, Watanabe Y, Toda K, Okazaki Y, Asaishi K, Hirata K, Narimatsu E. A case of inflammatory breast cancer treated with medroxyprogesterone acetate (MPA) in combination with intra-arterial infusion chemotherapy. Gan to kagaku ryoho. Cancer & chemotherapy. 1992 Sep;19(11):1923-5.

Van Laere SJ, Van der Auwera I, Van den Eynden GG, Elst HJ, Weyler J, Harris AL, Van Dam P, Van Marck EA, Vermeulen PB, Dirix LY. Nuclear factor-κB signature of inflammatory breast cancer by cDNA microarray validated by quantitative real-time reverse transcription-PCR, immunohistochemistry, and nuclear factor-κB DNA-binding. Clinical cancer research. 2006 Jun 1;12(11):3249-56.

Van Laere SJ, Van der Auwera I, Van den Eynden GG, Van Dam P, Van Marck EA, Vermeulen PB, Dirix LY. NF-κB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/or ErbB2 overexpression and MAPK hyperactivation. British journal of cancer. 2007 Aug;97(5):659..

Van Der Burg, Bart; Der Saag, Paul T.van (1996). "Endocrinology and paracrinology". Molecular Human Reproduction. 2 (6): 433–8. doi:10.1093/molehr/2.6.433.

Fouad TM, Kogawa T, Liu DD, Shen Y, Masuda H, El-Zein R, Woodward WA, Chavez-MacGregor M, Alvarez RH, Arun B, Lucci A. Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis. Breast cancer research and treatment. 2015 Jul 1;152(2):407-16.

Yamauchi H, Woodward WA, Valero V, Alvarez RH, Lucci A, Buchholz TA, Iwamoto T, Krishnamurthy S, Yang W, Reuben JM, Hortobágyi GN. Inflammatory breast cancer: what we know and what we need to learn. The oncologist. 2012 Jul 1;17(7):89


Refbacks

  • There are currently no refbacks.